Work

Biomarkers of treatment effect in a phase II trial of velimogene aliplasmid in patients with metastatic melanoma.

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.15_suppl.e19058

Authors: Mary K Wloch, Dmitri D. Kharkevitch, Alice Chu, John Schulte, Larry R Smith, Richard T. Kenney, Alain Rolland

Institution: Vical (United States)

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3012140814

Cites:

Cited by:

Related to: 10